Factors regulating insulin-like growth factor binding protein-3 secretion from human hepatoma (HepG2) cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 78, Issue 2, 2001, Pages 131-135

  Kalme, T ^a   Loukovaara, M ^a   Koistinen, H ^a   Koistinen, R ^a   Seppala M ^a   Leinonen, P ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Growth hormone; Human serum; Insulin like growth factor

Indexed keywords

ESTRADIOL; GROWTH HORMONE; HYDROCORTISONE; INSULIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TAMOXIFEN; TESTOSTERONE;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HEPATOMA CELL; HUMAN; HUMAN CELL; PROTEIN SECRETION;

ADRENAL CORTEX HORMONES; CARCINOMA, HEPATOCELLULAR; GROWTH HORMONE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; LIVER NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0034835410     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(01)00089-9     Document Type: Article

References (27)

1. Insulin-like growth factor binding proteins: Mechanism of action at the cellular level
2. Insulin-like growth factor binding protein-3: A novel biomarker for the assessment of the synthetic capacity of hepatocytes in liver cirrhosis
3. Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma
4. Different forms of insulin-like growth factor-binding protein-3 detected in serum and seminal plasma by immunofluorometric assay with monoclonal antibodies
5. Competition for binding to insulin-like growth factor (IGF) binding protein-2,3,4, and 5 by the IGFs and IGF analogs
6. Serum insulin-like growth factor (IGF) binding protein responses to sc IGF-I administration in normal subjects and patients with growth hormone deficiency
7. Effects of recombinant human insulin-like growth factor-I (rhIGF-I) on total and free IGF-I concentrations, IGF-binding proteins, and glycemic response in humans
8. A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: Its use for diagnosis of GH deficiency
9. Measurement and characterization of insulin-like growth factor binding protein-3 in human biological fluids: Discrepancies between radioimmunoassay and ligand blotting
10. Characterization of the insulin-like growth factor axis in a human hepatoma cell line (PLC)
11. Evidence for insulin-like growth factor (IGF)-independent transcripitional regulation of IGF binding protein-3 by growth hormone in SKHEP-1 human hepatocarcinoma cells
12. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen
13. Short-term changes in serum insulin-like growth factors (IGFs) and IGF binding protein 3 after different modes of intravenous growth hormone (GH) exposure in GH-deficient patients
14. Cloning and expression of the growth hormone-dependent insulin-like growth factor binding protein
15. Cloning and expression of human insulin-like growth factor binding protein-3
16. Distribution of messenger RNAs of insulin like growth factor (IGF) binding protein-1 and protein-3 between parenchymal and non-parenchymal cells in rat liver
17. Coculture of primary rat hepatocytes and non-parenchymal cells permits expression of insulin-like growth factor binding protein-3 in vitro
18. Differential cellular synthesis of insulin-like growth factor binding protein-1 (IGFBP-1) and IGFBP-3 within human liver
19. Concentrations, release, and disposal of insulin-like growth factor (IGF)-binding proteins (IGFBP), IGF-I, and growth hormone in different vascular beds in patients with cirrhosis
20. Increased proteolysis of insulin-like growth actor-binding protein-3 (IGFBP-3) in noninsulin-dependent diabetes mellitus serum, with elevation of a 29-kilodalton (kDa) glycosylated IGFBP-3 fragment contained in the approximately 130- to 150-kDa ternary complex
21. Effect of insulin on the insulin-like growth factor system in children with new-onset insulin-dependent diabetes mellitus
22. Serum insulin-like growth factor-binding protein-3 levels in the diagnosis of acromegaly
23. Serum and follicular fluid levels of insulin-like growth factor I (IGF-I), IGF-II, and IGF-binding protein-1 and -3 during the normal menstrual cycle
24. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: The relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation
25. Estradiol increases the production of sex hormone-binding globulin but not insulin-like growth factor binding protein-1 in cultured human hepatoma cells
26. The effects of dexamethasone treatment on immunoreactive and bioactive insulin-like growth factors (IGFs) and IGF binding proteins in normal male volunteers
27. The evolution of changes in immunoreactive serum insulin-like growth factors (IGFs), IGF binding proteins, circulating growth hormone (GH) and GH-binding protein as a result of short-term dexamethasone treatment